Alessandra D'Alessandro Selected Research

NF-kappa B (NF-kB)

3/2018

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra D'Alessandro Research Topics

Disease

6	Inflammation (Inflammations) 01/2021 - 12/2013
2	Diarrhea 03/2018 - 10/2017
2	Esophageal Achalasia (Megaesophagus) 03/2017 - 01/2016
1	Fistula 01/2022
1	Colic (Abdominal Cramps) 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Dyspepsia (Indigestion) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 05/2018
1	Neuroinflammatory Diseases 03/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Colonic Neoplasms (Colon Cancer) 08/2016
1	Carcinoma (Carcinomatosis) 06/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Colitis 01/2016
1	Pathologic Constriction (Stenosis) 11/2015
1	Esophageal Stenosis (Esophageal Stricture) 11/2015
1	Glioma (Gliomas) 06/2015
1	Melanoma (Melanoma, Malignant) 06/2015
1	Neoplasms (Cancer) 06/2015
1	Shock 12/2013
1	Cholangitis 12/2013
1	Cholestasis 12/2013
1	Choledocholithiasis 12/2013
1	Coronary Disease (Coronary Heart Disease) 06/2012
1	Cardiac Arrhythmias (Arrythmia) 06/2012
1	Necrosis 01/2008
1	Atrial Fibrillation 01/2008

Drug/Important Bio-Agent (IBA)

4	palmidrolIBA 01/2021 - 01/2016
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 03/2018 - 06/2015
2	PPAR alphaIBA 03/2018 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2016 - 01/2016
1	N 30IBA 01/2022
1	AcidsIBA 01/2021
1	Insulin Lispro (Humalog)FDA Link 05/2018
1	AntidiarrhealsIBA 03/2018
1	NF-kappa B (NF-kB)IBA 03/2018
1	tat Gene Products (tat Protein)IBA 03/2018
1	Trans-Activators (Trans-Acting Factor)IBA 03/2018
1	EnzymesIBA 01/2018
1	EndocannabinoidsIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2017
1	Rifaximin (L 105)FDA Link 08/2016
1	Pregnane X ReceptorIBA 08/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2016
1	SodiumIBA 01/2016
1	Dextrans (Dextran)FDA Link 01/2016
1	SteroidsIBA 11/2015
1	Calcium-Binding ProteinsIBA 06/2015
1	Pentamidine (NebuPent)FDA LinkGeneric 06/2015
1	PlasticsIBA 12/2013
1	Nicotine FDA Link 06/2012
1	SmokeIBA 06/2012
1	CatecholaminesIBA 06/2012
1	Irbesartan FDA LinkGeneric 01/2008
1	von Willebrand FactorIBA 01/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2008
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	C-Reactive ProteinIBA 01/2008
1	Angiotensin IIIBA 01/2008

Therapy/Procedure

4	Therapeutics 03/2018 - 11/2015
2	Stents 01/2022 - 12/2013
1	Gastrectomy 01/2022
1	Chemoprevention 08/2016
1	Aftercare (After-Treatment) 01/2016
1	Myotomy 01/2016
1	Heller Myotomy 01/2016
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 12/2013
1	Endoscopic Sphincterotomy 12/2013
1	Laser Lithotripsy 12/2013